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ABSTRACT
DNA cytosine modifications are key epigenetic reg-
ulators of cellular processes in mammalian cells,
with their misregulation leading to varied disease
states. In the human malaria parasite Plasmodium
falciparum, a unicellular eukaryotic pathogen, lit-
tle is known about the predominant cytosine mod-
ifications, cytosine methylation (5mC) and hydrox-
ymethylation (5hmC). Here, we report the first identi-
fication of a hydroxymethylcytosine-like (5hmC-like)
modification in P. falciparum asexual blood stages
using a suite of biochemical methods. In contrast
to mammalian cells, we report 5hmC-like levels in
the P. falciparum genome of 0.2–0.4%, which are
significantly higher than the methylated cytosine
(mC) levels of 0.01–0.05%. Immunoprecipitation of
hydroxymethylated DNA followed by next genera-
tion sequencing (hmeDIP-seq) revealed that 5hmC-
like modifications are enriched in gene bodies with
minimal dynamic changes during asexual develop-
ment. Moreover, levels of the 5hmC-like base in gene
bodies positively correlated to transcript levels, with
more than 2000 genes stably marked with this mod-
ification throughout asexual development. Our work
highlights the existence of a new predominant cyto-
sine DNA modification pathway in P. falciparum and
opens up exciting avenues for gene regulation re-
search and the development of antimalarials.
INTRODUCTION
In eukaryotic cells, gene regulation at the epigenetic level
is integral to most, if not all, physiological processes. The
main epigenetic factors include nuclear architecture, non-
coding RNAs, the dynamic deposition and removal of hi-
stone modifications, and DNA methylation (1). Of these,
DNA cytosine methylation is the most stable epigenetic
mark and can be inherited over tens to hundreds of repli-
cation cycles and generations (2,3). It occurs at position 5
of the pyrimidine ring of cytosine (5mC) mainly in a CpG
dinucleotide context––sequences that are located in CpG is-
lands (occurring at 60% of all gene promoters), in repeti-
tive sequences, or in CpG island shores (4)––and is catal-
ysed by de novo C5-DNA methyltransferases or DNMTs
(5). Methylation of promoter CpG islands in a symmetric
manner results in transcriptional repression of the corre-
sponding gene due to poor recognition by transcription fac-
tors, and the recruitment of proteins involved in chromatin
remodelling such asmethyl DNA-binding proteins (MBPs),
which create a repressive chromatin environment (5). More-
over, deregulation of DNA methylation and establishment
of new DNA methylation patterns are associated with the
under- or over-expression of select genes, ultimately leading
to inflammation, cancer and other diseases (1,3).
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In 2009, 5-hydroxymethylcytosine (5hmC), a demethyla-
tion intermediate in the active [5mC to C] conversion path-
way, garnered interest as an important epigenetic regulator
(6,7). 5hmC is generated by the Fe2+- and 2-oxoglutarate-
dependent oxidation of 5mC by ten-eleven translocation
(TET) dioxygenase enzymes, with depletion of TET pro-
teins resulting in global reduction of 5hmC levels (7,8). Al-
though 5hmC levels are significantly lower than 5mC lev-
els in most cellular systems studied to date, the first clue
for its function comes from embyronic stem cells (ESCs)
and cells from the central nervous system (CNS), where
5hmC constitutes up to 0.7% of all modified cytosines
(6). In ESCs, 5hmC is enriched at gene bodies of actively
transcribed genes as well as within extended promoter re-
gions of Polycomb-repressed developmental regulators (9),
whereas in differentiated neurons, its presence within gene
bodies positively correlates to transcript levels (10–12):
this indicates that 5hmC’s role in transcriptional regula-
tion is cell type-, gene- and development stage-specific. Fi-
nally, misregulation of 5hmC is observed in neuronal dis-
orders such as Alzheimer’s disease, Huntington’s disease,
schizophrenia, etc. and cancers such as melanoma, pan-
creatic, haematopoietic malignancies, etc. (3,12–15) Taken
together, 5hmC is now considered to be the sixth base in
eukaryotic DNA and not just an intermediate in the 5mC
demethylation pathway.
In the case of the lethal human malaria parasite, Plas-
modium falciparum, epigenetic gene regulation, via spe-
cialized nuclear architecture, histone modifications, histone
variants and chromatin-associated non-coding RNAs gov-
erns stage-specific biology, as the parasite develops within
the human host and mosquito vector (16). For instance,
during P. falciparum asexual blood stage development in
humans, key processes such as clonally variant expression
of surface-exposed virulence factors and commitment to
transmission stages (gametocytes) are epigenetically regu-
lated by all of the above mechanisms, and associated to
disease pathogenesis (16,17). Furthermore, small molecules
that specifically target P. falciparum histone methylation
and acetylation have been shown to interfere with parasite
growth and survival in vitro and in vivo (18–21). However,
to date, the contribution of well-established cytosine modi-
fications to parasite gene regulation remains poorly under-
stood: one of the main deterrents has been the AT-rich na-
ture (∼80%A+T content) of the P. falciparum genome (22).
In fact, after decades of debate over the existence of 5mC in
P. falciparum (23–28), in 2013, LeRoch and colleagues iden-
tified 5mC in genomic DNA prepared from P. falciparum
asexual blood stages using mass spectrometry and bisul-
fite conversion followed by sequencing (BS-seq) (28). How-
ever, because BS-seq does not distinguish between 5mC and
5hmC (29), it still remains unclear as to what the levels of
cytosine methylation and hydroxymethylation are in P. fal-
ciparum, and if indeed they play a role in regulating parasite
gene expression.
To conclusively address this, we utilized a combination
of biochemical and cell biological techniques to evaluate
the presence of cytosine hydroxymethylation in the P. fal-
ciparum genome. We took particular care to work with par-
asite genomic DNA preparations devoid of contaminating
DNA from human white blood cells, which are normally
present during P. falciparum in vitro culture. We then used
a validated antibody-dependent immunoprecipitation ap-
proach to delineate genome-wide hydroxymethyl-cytosine
distribution at different stages of intra-erythrocytic devel-
opment. Our work challenges the current view of DNA cy-
tosine methylation in P. falciparum (28): we show that 5mC
is present at very low levels in the parasite genome (0.05%
from mass spectrometric analysis) and that a 5hmC signal
cannot be detected by mass spectrometry. Instead, a signal
more hydrophobic than 5hmC was consistently detected,
and we refer to this modification as ‘5hmC-like’ throughout
this report. We demonstrate that this modified form is the
predominant cytosine modification in P. falciparum (0.2–
0.4% from a variety of biochemical techniques) and that
its levels in gene bodies positively correlate with gene ex-
pression. We speculate that the high oxygen level in infected
erythrocytes may favor the deposition of unusual cytosine
modifications, some of which may be 5mC derivatives, over
5mC in asexual stages of the malaria parasites.
MATERIALS AND METHODS
In vitro culture of Plasmodium falciparum
Blood stages of the P. falciparum laboratory strain 3D7,
clone G7 and NF54varsporo were grown according to Trager
and Jensen (30) with a few changes. Briefly, a mixed
stage culture of P. falciparum was grown in white blood
cell (WBC)-free O+ human erythrocytes (prepared from
whole blood by treatment with leukocyte-specific filters)
at a hematocrit of 4% in Roswell Park Memorial Insti-
tute (RPMI) 1640 medium containing L-glutamine (Invit-
rogen) supplemented with 1% v/v Albumax II (Invitrogen)
and 200 M hypoxanthine (C.C.Pro). The cultures were
grown in a gas environment of 5% CO2, 1% O2 and 94%
N2 to a parasitemia of 3–8% before harvesting for down-
stream analysis. For synchronization, knob-positive para-
sites were selected by gelatin flotation using Plasmion (Fre-
senius Kabi) (31) and after re-invasion, treated twice with
5% sorbitol (Sigma) (32) to obtain parasites that were syn-
chronized within a window of approximately 4 h, as evalu-
ated by Giemsa staining.
Genomic DNA and RNA isolation
Infected human erythrocyte cultures at different para-
sitemia and synchronized at the ring (8–12 h post-invasion
(hpi)), trophozoite (28–32 hpi) or schizont (40–44 hpi) par-
asite stages were harvested and free parasites obtained by
saponin lysis (33). Subsequently, the parasite pellet was split
into two portions: one for genomic DNA extraction, the
other for total RNA extraction. Genomic DNA was pre-
pared using the DNeasy Blood and Tissue kit (Qiagen) or
the Nucleospin Tissue kit (Machery-Nagel) as per manu-
facturer’s instructions and treated with RNAse to remov-
ing any contaminating RNAmolecules. Additionally, to re-
move heme and its derivatives from the genomic DNA, it
was purified using magnetic bead-based clean up with Am-
pure XP beads (Beackman Coulter) at 1:1 ratio, according
tomanufacturer’s instructions. TotalRNAwas prepared us-
ing the miRNeasy mini kit (Qiagen), as per manufacturer’s
instructions, along with on-columnDNase digestion. DNA
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and RNA concentrations were measured using the Nan-
oDrop Spectrophotometer (Thermo Fisher Scientific) and
Qubit Colorimetric Assay (Thermo Fisher Scientific).
South-western blotting assays
South-western blotting assays of P. falciparum genomic
DNA and DNA standards (Methylated DNA standard
kit from ActiveMotif) were performed as previously de-
scribed (34), but without using a DNA-binding protein.
DNA prepared as described above from matched vol-
umes of WBC-free uninfected blood served as a control.
Primary antibodies used include anti-5mC (rabbit mon-
oclonal; Abnova), anti-5mC (mouse monoclonal; Euro-
gentec), anti-5hmC (mouse monoclonal; ActiveMotif) and
anti-5hmC (mouse monoclonal; Millipore) antibodies. No
cross-reactivity was observed between 5hmC and 5mC, 5fc,
5cac and 5C for the anti-5hmC antibodies (Source: Ac-
tive motif). HRP-conjugated secondary antibodies include
anti-rabbit IgG and anti-mouse IgG from GE LifeSciences
that were compatible with ECLWestern Blotting Detection
Reagents (Thermo Fisher Scientific).
ELISA-based 5hmC quantification in P. falciparum genomic
DNA
Quantification of 5hmC/5hmc-like levels in P. falciparum
genomic DNA was performed using the Global 5hmC
quantification kit (ActiveMotif) with a few modifications
to the manufacturer’s protocol. Briefly, a 50 ml solution
of genomic DNA (@ 50 ng/ml) was sonicated for 10 min
(20 s ON; 20 s OFF) using a pre-chilled Bioruptor (Diagen-
ode). This solution was then diluted to 2 ng/ml in sam-
ple dilution buffer provided with the kit, heat denatured at
98◦C for 10 min and stored on ice. Simultaneously, 5hmC
DNA standards (included in the kit and used to generate a
standard curve) as well as unmethylated and hydroxymethy-
lated DNA (Methylated DNA standard kit, ActiveMotif),
included as negative and positive controls, respectively, were
heat denatured at 98◦C for 10 min and stored on ice. Next,
assay wells were coated with a DNA binding solution and
incubated for 1 h at room temperature (RT). Once coating
was complete, 50 ml of genomic DNA samples, standards
or controls, was added to an assay well and incubated for 2
h at 37◦C. The subsequent steps, i.e. washing of wells, incu-
bation with primary and secondary antibody solutions and
developing of each reaction, were carried out as per manu-
facturer’s instructions. Finally, the OD of the colorimetric
reaction was measured at 450 nm within 5 min of develop-
ment using a Synergy 2Multi-DetectionMicroplate Reader
(Biotek). The percentage 5hmC/5hmC-like levels in each
sample were calculated after plotting a standard curve in
Microsoft Excel. Note that the primary antibody used was
a mouse anti-5hmC monoclonal antibody (ActiveMotif) at
1/1000 dilution and the secondary antibody used was anti-
mouse-HRP antibody (GELifesciences) at 1/2000 dilution.
ELISA-based 5mC quantification in P. falciparum genomic
DNA
Quantification of 5mC levels in P. falciparum gDNA was
performed using the methylated DNA quantification kit
(Abcam) according the manufacturer’s instructions. Briefly,
100 ng of DNA samples, positive and negative controls
(provided in the kit), were bound to assay wells for 90
min at 37◦C. Wells were washed three times and pri-
mary anti-5mC antibody was added to all assay wells for
1 h at RT. Wells were then washed and secondary anti-
body was added to all assay wells for 30 min at RT. The
subsequent steps of fluorescence developpement were car-
ried out according to manufacturer’s instrucations, and
RFU (Relative fluorescence units) was measured using a
Synergy 2 Multi-Detection Microplate Reader (Biotek) at
Excitation/Emission = 530/590nm. 5mC percentage in
each sample was calculated after plotting a standard curve
in Microsoft Excel.
Immunofluorescence assays
Anti-5hmC and anti-5mC immunofluorescent staining was
performed as previously described (35) with a few mod-
ifications. Free P. falciparum parasites were obtained af-
ter saponin lysis (33), washed with phosphate-bufffered
saline (PBS), and fixed with 0.0075% Glutaraldehyde / 4%
Paraformaldehyde for 30 min at RT. Cells were then perme-
abilized with 0.1% Triton X-100 in PBS for 15 min at RT
and DNA denatured by adding 4N HCl for 20 min at RT.
HCl was washed away and 100 mM Tris pH 8.0 was added
for 10 min at RT for neutralization. Cells were then washed
with PBS + 0.05% Tween-20 (PBST) and free aldehydes
were quenched using 50 mM NH4Cl in PBS before block-
ing with PBS + 3% Bovine SerumAlbumin. After blocking,
primary anti-5hmC (Mouse monoclonal, Activemotif) or
anti-5mC antibodies (Mouse polyclonal, Eurogentek) were
added at 1/250 dilution for 1 h at RT. Anti-Histone3 (Rab-
bit; Abcam) primary antibodies were also added as a pos-
itive control to stain the nucleus. Cells were then washed
three times with PBST and the following secondary anti-
bodies were added at 1:2000 dilution for 30min at RT: Goat
anti-Mouse conjugated to Alexafluor-488 and Goat anti-
Rabbit conjugated to Alexafluor-647. Finally, after washing
with PBS, 5 ml of cells were mounted in Vectashield fluores-
cent mounting medium and images were acquired using a
Deltavision Elite imaging system (GE Healthcare). Images
were processed using Fiji/ImageJ.
Preparation of cytoplasmic and nuclear extracts
Plasmodium falciparum cytoplasmic and nuclear extracts
were prepared from 3 ml of infected RBCs synchronized
at the R, T or S stages, harvested at a parasitemia of 6 to
8% as previously described (36). The only change was that
for nuclear fraction extraction, the extraction buffer was
changed to 20 mM HEPES pH 7.9, 600 mM NaCl and 1
mM DTT. The resulting cytoplasmic and nuclear fractions
were aliquoted, snap-frozen and stored at −80◦C until fur-
ther use. Protein concentration was measured using a Brad-
ford assay and the Qubit Colorimetric Protein Assay.
TET activity assay using P. falciparum nuclear extracts
TET-like activity of P. falciparum nuclear extracts was mea-
sured using the TET hydroxylase activity quantification
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kit (fluorometric) from Abcam as per manufacturer’s di-
rections. A total of 5 g of nuclear extracts was used
per reaction. As a positive control, human recombinant
TET1 protein (Abcam) was included in the assay. Ex-
tracts prepared as described above from matched volumes
of WBC-free uninfected blood served as an additional
control. The resulting fluorescence was measured at 530
nm excitation/590 nm emission using a Synergy 2 Multi-
Detection Microplate Reader. TET hydroxylase activity is
represented as nanograms of DNA converted per minute
per milligram of protein. This was calculated based on a
standard curve generated using Microsoft Excel.
Bisulfite (BS) and oxidative bisulfite (oxBS) sequencing
Treatment of genomic DNA prepared from P. falciparum
asexual stage parasites with sodium bisulfite alone (BS)
or with an oxidizing agent followed by sodium bisulfite
(oxBS) was initially performed for pilot experiments us-
ing the TrueMethyl® Whole Genome Bisulfite Sequenc-
ing kit (Cambridge Epigenetix) according tomanufacturer’s
instructions. Spike-in DNA controls to estimate bisulfite
conversion and oxidation efficiencies were provided with
the kit and added prior to the chemical treatments. The
treated DNA was further processed with the same kit to
generate DNA libraries that were compatible with Illumina
sequencing-by-synthesis. For the data presented in this re-
port, BS-seq and oxBS-seq libraries were prepared using the
Ovation® Ultralow Methyl-Seq with TrueMethyl® oxBS
module kit (NuGen) according to manufacturer’s instruc-
tions; spike-in controls were obtained fromCambridge Epi-
genetix as above. All libraries were multiplexed and run on
an Illumina NextSeq 500 as a paired-end run of 150 nt. The
resulting fastq file was demultiplexed using bcl2fastq2 Con-
version Software v2.17 (Illumina) and further analyzed as
described below.
Analysis of BS-seq and oxBS-seq data
Quality control of fastq files was performed using the
FastQC software (http://www.bioinformatics.babraham.ac.
uk/projects/fastqc/) after which Cutadapt v1.14 (37) was
used to cut adapter sequences and trim low quality bases
(Q < 20) from the 3′-end of reads. The resulting high-
quality reads were aligned to the P. falciparum 3D7 refer-
ence genome (http://genedb.org; v3, PlasmoDB v13.0) us-
ing Bismark v.0.14.5 (38). Duplicated reads were removed
from the raw alignments using SAMtools v0.1.19 (39) and
further filtered for quality (Q < 30). Properties of the BS-
and oxBS-seq datasets generated in this study and related
statistics are provided in Supplementary Table S1.
Spike-in analysis. We estimated the methylation conver-
sion rate of the BS- and oxBS-seq libaries using the six
spike-in controls provided by the TrueMethyl kit. These
spike-in controls contain an expected set of methylated
(both 5mC and 5hmC) and unmethylated (truth set)
loci. The fastq reads were aligned to the spike-in con-
trol sequences using the cegx-bsExpress algorithm (https:
//bitbucket.org/cegx-bfx/cegx bsexpress docker), and the
number of true positives and false positives were calculated
at varying read depths based on the conversion summary
provided by cegx-bsExpress. For BS-seq libraries, sensitiv-
ity for 5mCs was defined as the proportion of 5mCs from
the truth set that were called as methylated by our pipeline
at a given depth cutoff. Similarly, sensitivity for 5hmCs was
defined as the proportion of 5hmCs from the truth set that
were called as methylated by our pipeline at a given depth
cutoff. False positive rate (FPR) was calculated as the pro-
portion of unmethylated cytosines from the truth set that
were called as methylated by our pipeline at a given depth
cutoff. For oxBS-seq libraries, sensitivity of 5mCs was cal-
culated as described above, and FPR was calculated as the
proportion of unmethylated cytosines and 5hmCs from the
truth set that were called as methylated by our pipeline
at a given depth cutoff. At depth ≥5× and % of methy-
lated reads ≥10% (i.e. ≥1 read), we observed a sensitivity
of ≥96% and a FPR of ≥2.5% (Supplementary Table S2).
These cutoffs were used for all subsequent analyses.
Methylkit-based determination of 5hmC loci. De-
duplicated and filtered alignments were used as inputs
to methylKit v0.9.2 (40) to estimate methylation per-
centages at CpG, CHG and CHH contexts. Loci with a
minimum read coverage of 5× with at least 1 methylation-
containing read were considered for down-stream analysis
based on our spike-in results. The resulting calls from the
BS-seq and oxBS-seq samples were compared to identify
5mC and 5hmC/5hmC-like loci. Specifically, loci that
were found to be methylated in both BS-seq and oxBS-seq
were classified as 5mCs whilst those that were methylated
in BS-seq and unmethylated in oxBS-seq were classified
as 5hmCs or 5hmC-like bases. Alternately, we processed
the de-duplicated alignments using Methpipe (41) and
identified between 34–70% of the 5hmC/5hmC-like loci
identified by Methylkit. We decided to use the Methylkit
lists for downstream analysis.
Data were visualized using the Integrative Genomics
Viewer (IGV) browser v.2.3.90 (42). For representation of
5hmC/5hmC-like genome-wide distribution, the coverage
of each mark was calculated as average reads per million
over bins of 2000 nt using bedtools v2.19.0 (43) and corre-
lations between the genome-wide distributions were calcu-
lated using deeptools2 v3.1.1 (44).
hmeDIP-seq and RNA-seq library preparation and sequenc-
ing
Hydroxymethylated DNA Immunoprecipitation (hmeDIP)
was performed using the hmeDIP kit from ActiveMotif ac-
cording to manufaturer’s instructions. The starting material
was genomic DNA from the Ring stage sheared using a pre-
chilled Bioruptor (Diagenode) for 10 min, 30 s ON and 30
s OFF to a size of 200–400 bp. The immunoprecipitated
DNA was processed using the MicroPlex Library Prepara-
tionKit v2 (Diagenode) with theKAPAHifi polymerase for
library amplification. All libraries weremultiplexed and run
on an Illumina NextSeq 500 as a paired-end run of 150 nt.
The resulting fastq file was demultiplexed using bcl2fastq2
Conversion Software v2.17.
For transcriptomic analysis, 4 g of total RNA from
Ring or Schizont stage parasites was poly(A)-enriched us-
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ing the Dynabeads mRNA purification kit (Thermo Fisher
Scientific), and used for strand-specific RNA-seq library
preparation with the TruSeq Stranded mRNA LT Sample
Prep Kit (Illumina) according to manufacturer’s instruc-
tions. The only change was that library amplification was
performed using KAPA Hifi polymerase (KAPA Biosys-
tems). All libraries were multiplexed and run on an Illu-
mina NextSeq 500 as a paired-end run of 150 nt. The re-
sulting fastq file was demultiplexed using bcl2fastq2 Con-
version Software v2.17.
Analysis of hmeDIP-seq and RNA-seq data
Quality control of fastq files was performed using the
FastQC software (http://www.bioinformatics.babraham.ac.
uk/projects/fastqc/) and Cutadapt. High quality reads were
mapped to the P. falciparum 3D7 genome (http://genedb.
org; v3, PlasmoDB v13.0) using the Burrows-Wheeler
Alignment tool Bowtie 2 v.2.2.3 under default settings (45).
SAMTools was used to remove duplicates for all hmeDIP-
seq samples. Properties of the RNA-seq and hmeDIP-seq
datasets generated in this study and related statistics are
provided in Supplementary Table S1.
For hmeDIP-seq analysis, deduplicated bam files filtered
for quality (Q > 30) using SAMtools served as a start-
ing point to identify enriched peaks in immunoprecipi-
tated DNA relative to the genomic DNA input. First, cor-
relation of the bam files of the different stages was cal-
culated using bedtools and deepTools2. Second, enrich-
ment peaks were identified using the MACS2 software
(46) after controlling for a false discovery rate (q-value)
of 1%. Correlation of the different MACS2 peak files
was determined using deepTools2 and bedGraphtobigwig
as previously described (https://github.com/taoliu/MACS/
wiki/Build-Signal-Track). Linear coverage plots were visu-
alized using the IGV browser. Gene Ontology (GO) analy-
sis was performed in PlasmoDB (https://plasmodb.org) and
reductionist analysis of GO terms performed using Revigo
(47).
For RNA-seq analysis, bam files were filtered down to
either the gene body (exons and introns) or exonic regions
alone using bedtools. The resulting alignments were used
as inputs to the featureCounts (48) from Subread v1.5.2 to
count the number of non-duplicate, uniquely aligned (map-
ping quality > 30) reads per gene. Custom R function was
used to calculate FPKM (Fragments Per Kilobase of tran-
script per Million mapped reads) per gene from the raw
counts.
Identification and quantification of 5hmdCand 5mdC inPlas-
modium falciparum DNA by LC-MS/MS
Purified P. falciparum genomic DNA was hydrolyzed en-
zymatically as described (49–51) with a modified proto-
col. The digestion mix contained 10 mM Tris–HCl (pH
7.9), 1 mM MgCl2, 5 U Benzonase (99% Purity Merck
71206), 50 M Desferroxamine (Sigma D9533), 0.1 g/l
Pentostatin (Sigma SML0508), 100 M Butylated hydrox-
ytoluene (Sigma W218405), 0.5 g/l Tetrahydrouridine
(Calbiochem 584222), 5 U Bacterial Alkaline Phosphatase
(Thermo Fischer 18011015), 0.05 U Phosphodiesterase I
(Affymetrix P3243). Hypersil GOLD aQ column [100 ×
2.1 mm, 1.9 m (Thermo Scientific 25305)] was used to re-
solve the digested deoxyribonucleosides in a two-buffer elu-
ent systemwhich was composed as follows: buffer A= 0.1%
formic acid in water and buffer B = 0.1% formic acid in
acetonitrile). Synthetic hm5dC and m5dC were purchased
from Cayman Chemicals (Items 18 162 and 16 166, respec-
tively). HPLC was performed at a flow rate of 300 l/m
at 25◦C. The gradient of 0.1% formic acid in acetonitrile
was as follows: 0–12 min, held at 0%; 12–15.3 min, 0%-
1%; 15.3–18.7 min, 1%-6%; 18.7–20 min, held at 6%; 20–
24 min, 6%-100%; 24–27.3 min, held at 100%; 27.3–28 min,
100%-0%; 28–41 min, 0%. The HPLC column was directly
connected to an Agilent 6490 triple quadrupole mass spec-
trometer with ESI Jetstream ionization operated in positive
ion mode. The voltages and source gas parameters were as
follows: gas temperature: 200◦C; gas flow: 15 l/min; nebu-
lizer: 30 psi; sheath gas temperature: 300◦C; sheath gas flow:
12 l/min; capillary voltage 1800 V and nozzle voltage, 0V.
The molecular transition ions were quantified in multiple-
reaction monitoring (MRM) mode.
Statistical analyses
For biochemical assays (5hmC quantification and TET ac-
tivity assay), a minimum of three biological replicates were
analyzed. Statistical analysis was performed in Microsoft
Excel 2008. Results were plotted using Plotly (52).
For differences in mRNA expression between hydrox-
ymethylated and unhydrooxymethylated gene sets, after a
preliminary analysis in Microsoft Excel 2008 to determine
sample variance, P-values were calculated using the non-
parametric Mann–Whitney U-test. Box plots were gener-
ated using Plotly.
RESULTS
Identification of a 5hmC-like modification in the genome of
the malaria parasite P. falciparum
To examine the presence of unexplored cytosine modifica-
tions in P. falciparum, we denatured genomic DNA pre-
pared from parasites of the 3D7-G7 strain (53) grown in
WBC-free blood, spotted them onto nylon membranes and
probed the membrane with either anti-5mC or anti-5hmC
antibodies from different sources (see ‘Materials andMeth-
ods’ section). Genomic DNA prepared from all three stages
(synchronized at the Ring (R; 8–14 h post-invasion (hpi)),
Trophozoite (T; 24–28 hpi) and Schizont (S; 38–42 hpi)),
reacted with the anti-5hmC antibodies, indicating the pres-
ence of a new DNA modification, 5hmC or 5hmC-like, in
the parasite genome: Figure 1A and Supplementary Figure
S1A show typical examples of our south-western blotting
results, with DNA preparations from uninfected WBC-free
blood showing zero reactivity to all antibodies tested (Sup-
plementary Figure S1B). Additionally, we performed im-
munofluorescence assays on fixed 3D7-G7 parasites using
the primary antibodies from Figure 1A and observed that
the fluorescence signal was restricted to the nucleus, fur-
ther supporting the existence of this novel DNA modifica-
tion in vivo (Figure 1B). Finally, we used an ELISA-based
assay to quantify the levels of this new modification in P.
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Figure 1. A 5hmC-like modification is the predominant cytosine modification in the Plasmodium falciparum genome. (A) Southwestern blotting analysis
of genomic DNA prepared from Ring (R), Trophozoite (T) or Schizont (S) stage P. falciparum 3D7-G7 parasites using antibodies against 5mC (Abnova)
or 5hmC (Activemotif). Unmethylated, methylated or hydroxymethylated DNA standards (Activemotif) served as controls. The total amount of DNA
used is indicated in ng. (B) Immunostaining of Ring (R) or Schizont (S) stage P. falciparum 3D7-G7 parasites with anti-5hmC (top) or anti-5mC (bottom)
antibodies. Anti-histone H3 antibodies were used as a positive control for nuclear staining. BF = Brightfield. (C) ELISA-based quantification of 5hmC
(blue) or 5mC (gray) levels in genomic DNA prepared from Ring (R) or Schizont (S) stage parasites of the NF54varsporo and 3D7-G7 strains. The positive
controls were the methylated (5mC) and hydroxymethylated (5hmC) DNA standards used in part 1A. Data were calculated as a percentage and represent
the means of three independent experiments + standard errors of means (S.E.M.).
falciparum genomic DNA extracted from two strains, 3D7-
G7 and NF54varsporo(54), and found that its levels varied be-
tween 0.19–0.38% during asexual development (Figure 1C).
Interestingly, the ELISA-based quantification yielded very
low numbers for 5mC levels in the P. falciparum genome, at
0.01–0.02%; this is in contrast to the report from Ponts et al.
(28) that identified substantially higher 5mC levels (0.47–
0.58%) in P. falciparum genomic DNA by mass spectrome-
try. The observed dominance of a 5hmC-like modification
over 5mC in a eukaryotic genome is unprecedented (55–57)
(Figure 1C and Supplementary Figure S1C) and indicates
that the parasite might have evolved to use the 5hmC-like
modification in a unique manner.
We also queried if TET proteins, the writers of 5hmC,
are expressed by P. falciparum asexual stage parasites. We
first measured TET hydroxylase activity in nuclear extracts
prepared fromRing and Schizont stages ofP. falciparum us-
ing an ELISA-based colorimetric assay, with extracts from
uninfected WBC-free blood serving as a negative control,
and detected TET-like activity in all parasite samples, with
highest activity in Ring stage nuclear extracts, indicating
that a TET-like protein is indeed expressed by the parasite
(Supplementary Figure S2). However, the latest annotation
of the P. falciparum genome does not include a TET ho-
mologue or orthologue neither could we identify a TET-
like protein in P. falciparum using hidden markov model
(HMM)-based predictions. The identification of the gene(s)
coding for the observed enzymatic activity, however, is be-
yond the scope of this report. Nonetheless, our data, for the
first time, establish the presence of a 5hmC-like modifica-
tion in the genome of a eukaryotic pathogen.
Hydroxymethylation is the predominant cytosine modifica-
tion in P. falciparum asexual stages
Thereafter, to determine the genome-wide distribution of
the 5hmC-like modification at single nucleotide resolution,
we performed bisulfite sequencing (BS-seq) and oxidative
bisulfite sequencing (oxBS-seq) of genomic DNA derived
from two developmental stages, Ring (R; 8–14 hpi) and
Schizont (S; 38–42 hpi)––stages that have distinct tran-
scriptomic profiles (58,59)––of two P. falciparum strains,
3D7-G7 and NF54varsporo, using the TrueMethyl technology
(60,61) (Figure 2A). Briefly, we treated genomic DNA sup-
plemented with tailed spike-in controls with sodium bisul-
fite alone (Figure 2A; top), or sequentially with the ox-
idizing agent potassium perruthenate and sodium bisul-
fite (Figure 2A; bottom) to yield BS (5mC + 5hmC (or
5hmC-like)) and oxBS (5mC) samples, respectively. These
were then processed for multiplexed Illumina sequencing-
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Figure 2. BS- and oxBS-seq profiling confirms that a majority of modified cytosines in Plasmodium falciparum are 5hmC-like in nature. (A) Schematic
representation of the BS- and oxBS-seq methodology. Genomic DNA prepared from synchronizedP. falciparum parasites was treated with sodium bisulfite
alone (BS-seq; top panel) or with an oxidizing agent prior to sodium bisulfite treatment (oxBS-seq; bottom panel). The resulting DNA was processed for
Next Generation Sequencing and a subtraction of oxBS-seq signals from BS-seq signals yielded 5hmC distribution at single nucleotide resolution. See
‘Materials and Methods’ section for additional details. (B) Measured 5hmC (blue) or 5mC (grey) levels (relative to total cytosines in the P. falciparum
genome, at 5 dpge and 10% methylation proportion and represented as a percentage) in Ring (R) or Schizont (S) stage BS- and oxBS-seq samples for the
NF54varsporo and 3D7-G7 strains. Data represent the means of three independent experiments + S.E.M. (C) Pearson correlation analysis of the 5hmC-like
profiles (calculated for bigwig files normalized over 500 nt bins) for the different BS- and oxBS-seq replicates for genomic DNA extracted from Ring (R) or
Schizont (S) stage parasites of the NF54varsporo and 3D7-G7 strains. The colour scale indicates the value of the Pearson Correlation Coefficient R from −1
to 1. (D) Overlap in the number of 5hmC-like loci identified in BS- and oxBS-seq replicates of the indicates samples of theNF54varsporo and 3D7-G7 strains.
(E) The percentage of 5hmC-like loci found in the CpG (black), CHG (yellow) or CHH (white) context was calculated for the indicated parasite strain and
growth stage: R = Ring and S = Schizont, from the BS- and oxBS-seq data. Data represent the means of three independent experiments + S.E.M.
by-synthesis and the resulting libraries sequenced using a
paired-end run of 150 nt. After performing quality control
analysis of fastq files (Supplementary Table S1), conversion
efficiency of the spike-in controls was measured for each
sample using cegx-BSexpress (Supplementary Figure S3A–
H), and sensitivity and FPR values estimated at varying se-
quencing depths (≥5, ≥10, ≥20 and ≥30) and methylation
proportion (i.e. % of reads supporting methylation at the
given sequencing depth) with a P-value cutoff of 0.05 (Sup-
plementary Table S2). Based on this, we chose a sequencing
depth of≥5 and amethylation proportion cutoff of 10% for
downstream analysis.
Next, the fastq files were aligned to the P. falciparum
genome (http://genedb.org; v3) using a bisulfite-aware al-
gorithm, Bismark (38), and the numbers of methylated cy-
tosines calculated for each sample (Supplementary Table
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S3); this preliminary examination indicated that∼0.3–0.4%
of the sequenced cytosines were modified in the three bio-
logical replicates of the R and S samples from both strains.
The data were further processed using Methylkit (40) to
identify 5hmC (or 5hmC-like) and 5mC loci at the parame-
ters specified above, resulting in an average of 8897 5hmC-
like loci for the NF54varsporo R stage or 0.20% of all ge-
nomic cytosines (Cs; numbering 4512612 in the P. falci-
parum genome), 9490 5hmC-like loci for the NF54varsporo S
stage or 0.21% of all Cs, 11872 5hmC-like loci for the 3D7-
G7 R stage or 0.26% of all Cs, and 11640 5hmC-like loci
for the 3D7-G7 S stage or 0.26% of all Cs (Figure 2B; Sup-
plementary Tables S4 and 5)––these values are compara-
ble to those observed in Figure 1C. Moreover, we detected
very low levels of 5mC in the parasite, with a total of 680–
720 unique 5mC loci in the various samples accounting for
0.01–0.02% of genomic cytosines (Supplementary Figure
S4A and Tables S6-7).
We next performed a Pearson Correlation analysis of the
5hmC-like profiles of NF54varsporo R & S and 3D7-G7 R
& S replicates and found to our surprise that the corre-
lation coefficient R ranged from −0.85 to 1 (Figure 2C),
with replicates of the same strain and stage showing vari-
able correlations––for example, the biological replicates of
the NF54varsporo R and 3D7-G7 S stages were positively cor-
related, whilst those of the NF54varsporo S and 3D7-G7 R
stages were not. This was emphasized by the low overlap in
the exact nucleotide position of the 5hmC-like loci amongst
biological replicates (Figure 2D). Technical replicates for a
single genomic DNA sample further confirmed this obser-
vation (Supplementary Figure S5). Because our analysis of
the spike-in DNA controls indicated that both oxidation
and bisulfite conversion efficiencies of the BS- and oxBS-
seq methods are close to 100% for non-parasite DNA (Sup-
plementary Figure S3), we conclude that this method gen-
erates incomplete bisulfite modifications when applied to
the high AT-rich P. falciparum genome (>80%AT content).
We therefore decided to use another reference method to
perform genome-wide 5hmC-like analysis of P. falciparum
blood stage DNA.
hmeDIP-seq reproducibly identifies the genome-wide distri-
bution of 5hmC-like modifications in P. falciparum
Hydroxymethylated DNA immunoprecipitation (hmeDIP)
followed by next generation sequencing (-seq) is routinely
used to characterize the distribution of 5hmC (62–64). For
P. falciparum hmeDIP-seq, we isolated genomic DNA from
three biological replicates of the 3D7-G7 strain synchro-
nized at the Ring (R; 6–10 hpi), Trophozoite (T; 24–28
hpi) and Schizont (S; 38–42 hpi) stages, sheared the DNA
to fragments that were 300–400 bp in size and immuno-
precipitated 5hmC-enriched DNA using anti-5hmC anti-
bodies (Figure 3A); rabbit IgG antibodies were used as
a negative control for immunoprecipitation (IP). The im-
munoprecipitated DNAwas processed for multiplexed Illu-
mina sequencing-by-synthesis and the resulting libraries se-
quenced using a paired-end run of 150 nt. After performing
quality control analysis of fastq files (Supplementary Ta-
ble S1), the sequences were aligned against theP. falciparum
genome (https://genedb.org; v3) to yield BAM files.
Given that hmeDIP-seq has been standardized for
genomes with higher G+C content as compared to P. falci-
parum such as humans and mice, and given the poor perfor-
mance of BS- and oXBS-seq for the P. falciparum genome
(Figure 2), we first evaluated the reproducibility of our
hmeDIP-seq experiments by measuring the Pearson corre-
lation coefficient R values between the various BAM align-
ment files. As shown in Figure 3B, we observed a segrega-
tion of the hmeDIP-seq samples into a cluster that is dis-
tinct from the IgG control IPs and the Input DNA sam-
ples, which were also processed for Illumina sequencing-by-
synthesis as described above. In fact, the control reactions
were better correlated to the Input DNA samples as com-
pared to the hmeDIP-seq samples. Interestingly, the values
of R ranged from 0.8 to 1.0 between the Ring, Trophozoite
and Schizont stage hmeDIP-seq samples suggesting that the
5hmC-like profiles of the P. falciparum genome at different
growth stages might be similar.
Next, we used the peak-calling software ‘Model-based
analysis of ChIP-seq’ orMACS2 (46) to delineate hmeDIP-
enriched regions of the P. falciparum genome relative to
the corresponding Input DNA. A similar analysis was per-
formed for the IgG control IPs. When we evaluated the
Pearson correlation coefficient R values between the vari-
ous MACS2 fold enrichment (FE) profiles, we found that
the ‘hmeDIP versus Input’ FE profiles of various growth
stages clustered independently from the ‘control IP versus
Input’ FE profiles (Figure 3C). A similar separationwas ob-
served using a Principal Component Analysis (PCA) anal-
ysis, along the second principal component axis (Figure
3D). Of note, in the PCA analysis, the Trophozoite stage
‘hmeDIP versus Input’ FE profile segregated distinctly from
the Ring and Schizont stage FE profiles along the first prin-
cipal component axis. Taken together, we conclude that
hmeDIP-seq performs reproducibly and robustly to study
the distribution of 5hmC-like marks in the P. falciparum
genome.
The 5hmC-like modification is predominantly found in gene
bodies and appears to be stably maintained during intra-
erythrocytic development
We calculated the number of MACS2-derived, hmeDIP-
enriched peaks in the Ring, Trophozoite and Schizont sam-
ples at a log2(fold change) ≥ 1 and false discovery rate <
0.05 and identified 4148, 4603 and 4080 peaks, respectively
(Supplementary Table S8). Of these, 98–98.5% of the peaks
mapped to genic regions, described here as the region cov-
ering 1 kb upstream of START codon, gene body (introns
and exons) and 1 kb downstream of STOP codon (Figure
4A). The remaining 1–1.5%of the so-called intergenic peaks
mapped to chromosome ends, primarily to telomeric se-
quences (Supplementary Figure S6). This observation is not
surprising given the abundance of cytosines in gene bodies
and telomeric ends relative to the rest of the P. falciparum
genome (22). Furthermore, the cytosines in these regions
are predominantly in the CHH context, suggesting that a
majority of the modified cytosines in the parasite genome
may be in an asymmetric context, as was revealed by the
BS- and oxBS-seq analysis in Figure 2E.
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Figure 3. hmeDIP-seq performs robustly for the AT-rich Plasmodium falciparum genome. (A) Schematic representation of the hmeDIP-seq methodology
used tomeasure 5hmC (or 5hmC-like) distribution inP. falciparum asexual stages. ShearedP. falciparum genomicDNAwas immunoprecipitated using anti-
5hmC antibodies and the resulting DNA processed for Next Generation Sequencing (NGS). MACS2 was used for 5hmC-like peak-calling. See Materials
and Methods for additional details. (B) Correlation between hmeDIP-seq biological replicates (calculated for bam alignment files derived from Illumina
sequencing data) for the Ring (R), Trophozoite (Troph or T) and Schizont (Schiz or S) stages of 3D7-G7 was determined using a Pearson correlation
analysis. The colour scale indicates values of the Pearson correlation coefficient R from 0 to 1. Ctrl = Control IP for biological replicate 1. A and B
are technical replicates for the same genomic DNA sample. (C) Correlation of MACS2 fold enrichment (FE) profiles of hmeDIP-seq samples relative to
Input DNA for the Ring (R), Trophozoite (T) and Schizont (S) stages of 3D7-G7 was compared to the IgG control IPs relative to Input DNA. For each
stage, data were normalized across all replicates to generate a single FE profile (described in ‘Materials and Methods’ section). The colour scale indicates
values of the Pearson correlation coefficient R from 0 to 1. Ctrl = Control IP for biological replicate 1. (D) Principal Component Analysis of the different
MACS2-derived FE profiles of part C was performed using the plotPCA function of DeepTools on a multibigwigsummary file. The eigenvalues of the
top two principal components PC1 (54.3% of variance explained) and PC2 (31.3% of variance explained) are shown and meaningful clustering of samples
indicated.
We then identified the genes that are associated with
5hmC-like loci by intersecting the hmeDIP-enriched peaks
with annotated features of the P. falciparum genome (Sup-
plementary Table S9). As shown in Figure 4B, 2539, 2735
and 2507 genes have this cytosine modification in the Ring,
Trophozoite and Schizont stages, respectively, and a major-
ity of these genes carry the modification within the gene
body relative to the 1 kb upstream and downstream re-
gions. However, there are some instances wherein a gene
has 5hmC-like modifications in its gene body as well as
in the 1 kb upstream and/or downstream regions, indicat-
ing that the MACS2-derived peak is spread across multi-
ple areas of the same genic region (Figure 4B). We also an-
alyzed the overlap in the 5hmC-like-associated genes be-
tween the different growth stages and found that ∼2200
genes, i. e.>80%, are stably marked with 5hmC-like modifi-
cations in the Ring, Trophozoite and Schizont stages (Fig-
ure 4C). An example of a stably modified region of chro-
mosome 4 is shown in Figure 4D. Nonetheless, there are
some genes that appear to be dynamically marked during
the Ring-Trophozoite-Schizont-Ring transitions (Supple-
mentary Figure S7) and point to potentially specific roles
of the 5hmC-like mark in gene regulation and parasite de-
velopment.
5hmC-like levels within gene bodies positively correlate with
P. falciparum gene expression
Given that a majority of hmeDIP-enriched peaks were
distributed within genic regions, more specifically within
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Figure 4. 5hmC-like bases occur predominantly in genic regions of the Plasmodium falciparum genome and are stably maintained during intra-erythrocytic
development. (A) The number of hmeDIP-enriched peaks found in genic (red bars; 1 kb upstream, green bars; gene body and blue bars; 1 kb downstream)
and intergenic (black bars) regions was calculated for the indicated growth stage from the hmeDIP-seq data: Troph = Trophozoite and S = Schizont. (B)
Genes containing 5hmC-like loci either in the gene body or within their 1 kb upstream or downstream flanks were identified for the Ring, Trophozoite
(Troph) and Schizont (Schiz) stages of the 3D7-G7 strain. A Venn diagram was used to represent the overlap in 5hmC-like-associated genes for the different
sub-domains of a genic region. (C) A Venn diagram was used to represent the overlap in 5hmC-like-associated genes for the indicated sub-region across
different P. falciparum growth stages: Troph = Trophozoite and S = Schizont. (D) The hmeDIP-seq and MACS2-derived fold enrichment (FE) pofiles for
a 35 kb region of chromosome 4 (dark blue) are shown for the Ring, Trophozoite (Troph) and Schizont (Schiz) stages. MACS2-derived peaks are shown
underneath the FE profiles. The coverage of bam files for hmeDIP-enriched DNA (red), DNA enriched in the control IP (green), or Input DNA (black)
is shown and was calculated as reads per million over bins of 1000 nt. The GC plot (light blue) represents the G+C content of the P, falciparum genome
normalized across bins of 1000 nt.
gene bodies (Figures 4A and B), we asked if gene body
5hmC-like levels correlated with mRNA expression. We
performed RNA-seq-based transcriptomic analysis of to-
tal RNA isolated from the parasite cultures that were used
for genomic DNA preparation and extracted reads that
mapped to ∼5670 P. falciparum genes (Supplementary Ta-
ble S10; fragments per kilobase of transcript per million
reads or FPKM). Next, for each stage and each replicate,
we compared the average expression of genes that were hy-
droxymethylated in the gene body to unhydroxymethylated
genes and found that hydroxymethylated genes had signifi-
cantly higher levels of mRNA expression in all stages anal-
ysed in this study (Figure 5A; Supplementary Figure S8
and Table S11A). A similar correlation has been observed
in neuronal cells, where 5hmC levels in gene bodies pos-
itively correlates with transcriptional activity (10–12). In-
terestingly, we found that hydroxymethylation in the 1 kb
upstream and 1 kb downstream regions of genes also cor-
related with higher gene expression (Supplementary Tables
S11B and C), with a stronger effect of 5hmC-like peaks in
the 1 kb downstream regions on gene expression. However,
because a majority of these peaks are contiguous with gene
body peaks, we cannot attribute a regulatory role to them
at this stage.
We next evaluated whether the 2178 genes that main-
tain gene body hydroxymethylation in the Ring, Tropho-
zoite and Schizont stages (Figure 4C) have higher expres-
sion throughout the parasite lifecycle. We measured aver-
age transcriptional activity of these genes for each stage
(and each replicate) and compared them to the remain-
ing genes. As shown in the inset in Figure 5B and Supple-
mentary Table S11D, the steady state mRNA levels of the
stably hydroxymethylated genes were significantly higher
than the remaining P. falciparum genes in all three stages.
Gene ontology (GO) analysis revealed that these genes
are enriched for GO terms such as nucleus, myosin com-
plex, cytoskeleton, regulation of RNA metabolic process,
inorganic anion transport, translational initiation, protein
phosphorylation, carbohydrate derivative binding, purine
ribonucleoside triphosphate binding, ion binding, nucleic
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Figure 5. 5hmC-like distribution within gene bodies is positively correlated to mRNA levels. (A) The expression of genes with (green) or without (red)
5hmC-like peaks in the gene body is displayed as a box and whisker plot for one replicate of the Ring (Rep 1), Trophozoite (Troph; Rep 1) and Schizont
(Schiz; Rep 1) stages of the 3D7-G7 strain. For each box and whisker plot, the mean is indicated as a dashed line and the median as a solid line within
the box. Y-axis: FPKM (fragments per kilobase of transcript per million mapped reads) measured using strand-specific RNA-seq. For each comparison,
P-values were calculated using the non-parametric Mann–Whitney U-test. * indicates a P-value < 0.001. Refer to Supplementary Figure S5 and Table
SS5A for the other replicates (B) Left panel: The intersection of 5hmC-like-associated genes (peaks within gene body) identified in the Ring, Trophozoite
(Troph) and Schizont (Schiz) stages of the 3D7-G7 strain are represented using a Venn diagram. Right panel: The table summarizes the expression (Average
RPKM) of 2178 overlapping genes relative to the remaining genes in replicate 1 of the indicated growth stage. The P-value was calculated using the non-
parametricMann–Whitney U-test. Refer to Supplementary Table S5D for the remaining replicates. (C) Gene Ontology (GO) analysis of genes that contain
5hmC-like loci within the gene body in all three stages of the 3D7-G7 strain was performed using https://plasmodborg. Background refers to the number
of genes annotated to the indicated GO term in the entire background set, which in this case is comprised of all annotated P. falciparum genes. MF =
Molecular Function; BP = Biological Process; CC = Cellular Component. Refer to Supplementary Table S6 for additional details.
acid binding, hydrolase activity (acting on acid anhydrides),
motor activity, DNA-binding transcription factor activity,
calmodulin binding and actin binding (Figure 5C and Sup-
plementary Table S12). Hence, it appears that housekeep-
ing pathways that are associated with the regulation of gene
expression, cellular signalling and cytoskeletal organiza-
tion may be fine-tuned via this newly discovered 5hmC-like
modification.
Mass spectrometry analysis posits the presence of a cytosine
DNAmodification in P. falciparum genomic DNA that is dis-
tinct from 5hmdC and 5mdC
To verify the presence of cytosine modifications in P. falci-
parum, we surveyed the P. falciparum genome using mass
spectrometry (MS). For this, we digested the genomic
DNA (gDNA) extracted from asexual blood stage para-
sites in the presence of anti-oxidants and deaminase in-
hibitors. Collision-induced dissociation (CID) causes the
loss of the 2′-deoxyribose moiety (m/z 116.1) from both
5-hydroxymethyl-2′-deoxycytidine (5hmdC) and 5-methyl-
2′-deoxycytidine (5mdC), leaving a protonated pyrimidine
ring for both bases with m/z ratios of 142.1 and 126.1, re-
spectively, which wasmonitored using anAgilent 6490QqQ
mass spectrometer (Supplementary Table S13). In order to
make our detection more robust, we used a second qualifier
transition of 258.1>124.1 and 258.1>109.1, which corre-
sponds to a further loss of a water and ammonia molecule
from the pyrimidine base for 5hmdC and 5mdC, respec-
tively (Figure 6 and Supplementary Figure S9). An anal-
ysis of the LC-MS chromatogram shows distinctly the elu-
tion of two species at 2.00 min and 3.71 min correspond-
ing to the commercial 5hmdC and 5mdC standards respec-
tively for both of the monitored transitions. These peaks are
also visible in the calf thymus DNA, which was used as a
positive control. Two biological replicates of hydrolysed P.
falciparum gDNA provided a very small signal for 5mdC
(∼0.05% of total dC content), confirming the results of the
biochemical methods that we used (Figures 1 and 2), and
failed to provide a signal for 5hmdC altogether. We, how-
ever, noticed the elution of a cryptic peak at 2.75 min and
5.72 min for the transitions that match 5hmdC and 5mdC
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Figure 6. hm5dC is not detectable in Plasmodium falciparum DNA by mass spectrometry but there is evidence for another type of modified nucleoside.
LC-MS/MS spectra captured usingMultiple ReactionMonitoring (MRM)mode are shown for two transitions, (A) 258.1>142.1 and (B) 258.1>124.1, for
two replicates (Rep 1 and Rep 2) of P. falciparum genomic DNA. Calf Thymus DNA and a synthetic standard purchased from Cayman Chemicals served
as positive controls, and showed hm5dC (i.e. 5hmC) elution at 2.00 min at room temperature. ? signifies an unknown peak that elutes at approximately 2.75
min for both transitions. The no DNA ‘Matrix’ control included enzymes, inhibitors and other buffers. Note that the y-axis scales of the various samples
are not linked.
respectively in P. falciparum gDNA (Figure 6 and Supple-
mentary Figure S9). Spiking in commercial 5hmdC stan-
dard in hydrolysed gDNA showed a concomitant increase
in the signal at 2.00 min and no change at 2.75 min indicat-
ing that the digestion matrix did not contribute to a shift
in the retention time and could not account for the cryptic
peak (Supplementary Figure S10). Taken together, the MS
data indicate the presence of a cytosine modification in P.
falciparum genomic DNA – corresponding to the unknown
peak that eluted at ∼2.75 min in Figure 6––that is distinct
from 5hmdC and 5mdC, and which remains to be charac-
terized.
DISCUSSION
In the past 10 years, cytosine hydroxymethylation has
emerged as an integral component of the epigenetic land-
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scape in higher eukaryotes. Nevertheless, its regulatory role
in model organisms and lower eukaryotes is relatively un-
explored, partly due to the very low levels of 5mC and/or
5hmC in these organisms (0.03–0.06%) (65–67). Impor-
tantly, cytosine hydroxymethylation or similar derivatives
have never been reported for a eukaryotic pathogen, mak-
ing our study the first such report. Indeed, our findings
that high levels of cytosine hydroxymethylation (0.2–0.4%)
is correlated to general gene expression in the malaria para-
site emphasize, once again, the need to study epigenetic pro-
cesses in non-model systems to gain insights into organism-
specific, novel modes of gene regulation.
Plasmodium falciparum epigenetic regulation governs
pathogenesis in humans (16,17) and therefore, for several
decades, there has been interest in studying the role of DNA
modifications in P. falciparum gene regulation. A number
of reports provided experimental evidence that the parasite
genome does not contain the so-called fifth DNA base 5mC
(23,24,26) and this was further supported by the absence
of DNMT1 and DNMT3 homologues in the malaria para-
site (22). One exception was the indirect detection of 5mC
within the genomic locus of the dihydrofolate reductase-
thymidine synthase (DHFR-TS) gene by restriction map-
ping (27). In 2013, Ponts et al. reported 5mC in genomic
DNA prepared from an asynchronous P. falciparum blood
stage culture using MS (0.36% to 1.31%) and BS-seq (28).
In the light of our data - we detect very low levels of 5mC
by MS in genomic DNA prepared from parasites grown
in blood free of white blood cells (Supplementary Figure
S9) - the reported values for cytosine methylation by Ponts
et al. could be attributed to several experimental shortcom-
ings. First, their methodology for genomic DNA prepara-
tion did not eliminate human white blood cells, which are
present during standard P. falciparum in vitro culture (rel-
evant to their MS observations); second, it is now well-
established that 5mC and 5hmC are not distinguished by
BS-seq (29); and third, the authors do not provide any in-
formation about the reproducibility of their BS-seq experi-
ments. Given that biological and technical replicates of BS-
and oxBS-seq were poorly correlated in our study, our data
challenge the results of Ponts et al. Moreover, our subse-
quent MS analyses demonstrate that a new cytosine mod-
ification(s) 5hmC-like exists in the parasite genome, which
may be less reactive than 5hmC with the oxidizing agent of
oxBS-seq, potassium perruthenate, and more reactive than
5mC and 5hmC with sodium bisulfite. Overall, we caution
that BS- and oxBS-seq has technical shortcomings that pre-
clude this method to study cytosine modifications in P. fal-
ciparum.
Our study also indicates that the new cytosine form,
5hmC-like, is consistently detected by a reference anti-
5hmC monoclonal antibody in asexual stages of P. falci-
parum. Because this monoclonal antibody has been widely
used in several model systems to detect 5hmC (9,55,62–
64), and because our biochemical studies are reproducible,
we infer that the anti-5hmC antibody is cross-reacting
with 5hmC-like in parasite genomic DNA. A similar cross-
reactivity has been observed for RNA modifications such
as N6-methyladenosine and N6,2′-O-dimethyladenosine
(m6Am) (68), and otherDNAandRNAmodifications (69).
The molecular basis of cross-reactivity awaits the chemical
chracterization of 5hmC-like. Nonetheless, the application
of anti-5hmC antibodies in hmeDIP-seq to study a new cy-
tosine mark and its genome-wide distribution is an impor-
tant outcome of our study. hmeDIP-seq also overcomes any
concerns that arise from incomplete chemical conversion in
BS- and oxBS-seq (70–72), especially in light of the AT-rich
nature of the P. falciparum genome, which lacks CpG is-
lands and contains Cs primarily in a CHH context (22).
Intriguingly, our biochemical data reveal a low
methylation/hydroxymethylation ratio in malaria par-
asites, which contrasts to the situation described in a
number of mammalian cell types, where 5mC is detected
at higher levels compared to 5hmC (55–57). For example,
in HEK293 cells, 5mC accounts for 4% of total Cs whilst
5hmC accounts for 0.12% (35); these numbers are even
lower in human pancreatic cells (73) (Supplementary Fig-
ure S1B). The exceptions include ESCs and different brain
tissues, where 5hmC has been detected at elevated levels
within gene bodies and has been associated to a role in gene
activation (10–12). In fact, the highest levels of 5hmC have
been observed in brain cells from the frontal cortex of adult
mice, with 5hmC at 0.87% of total Cs accounting for 17.2%
of modified Cs (10) (Supplementary Figure S1B). However,
the molecular basis of the dominance of 5hmC-like marks
over 5mC in P. falciparum is currently unclear. One pos-
sibility is that the high oxidative environment within the
infected erythrocyte may enhance the cytosine transition
from methylation to hydroxymethylation or other similar
derivatives such as 5hmC-like and determine their stability.
The genome-wide distribution pattern of 5hmC-like loci
in P. falciparum revealed that this mark is predominantly
genic in nature, with more than >95% of 5hmC-like peaks
mapping to gene bodies. This has been observed in other
cell types of higher eukaryotes where 5hmC was primar-
ily detected in enhancers and transcribed sequences and
was depleted from intergenic regions (9–11,62,64,74,75).
Consequently, 5hmC-like levels in the gene bodies of sev-
eral P. falciparum genes positively correlated to mRNA
levels, which is in agreement with studies in mouse ESCs
(11). Given that a majority of 5hmC-marked genes main-
tain the mark during asexual blood development, our data
suggest that this mark may add a layer of epigenetic con-
trol that favors higher transcriptional rates by introduc-
ing subtle changes in the chromatin, by influencing nucle-
osome positioning and/or by recruiting RNA polymerase
II to these genes. Nonetheless, genetic validation of the role
of 5hmC-like in P. falciparum gene regulation awaits the
identification of protein(s) involved in writing and reading
this cytosine mark. Our inability to identify an ortholog
to mammalian TET proteins by bioinformatic approaches
is not surprising: for Plasmodium spp., orthologs of con-
served pathways, structures or organelles are frequently dif-
ficult to identify by sequence homology alone––for exam-
ple, only a very small fraction of proteins constituting the
nuclear pore complex (NPC) can be identified in P. falci-
parum using bioinformatics tools (22) although the NPC
can be visualized using several imaging approaches (76).
We cannot exclude that this pathogen has evolved other
pathways for modified cytosine synthesis as has been sug-
gested for plants (77). Alternately, P. falciparummay co-opt
the SOS response-associated peptidase (SRAP) domain-
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containing protein PfSrap1 (PF3D7 1202100) for cyto-
sine dehydroxymethylation as has been observed in mouse
embryos (78).
Lastly, we applied mass spectrometry analysis of P. falci-
parum genomic DNA (free from leukocyte contamination)
to revisit the methylation of cytosine. For one, the Plasmod-
ium sample peaks for 5mdC are extremely low (∼0.05% of
total dC content) and undetectable for the second qualifier
transition (242.1 > 109.1), corroborating our results from
the ELISA-based 5mC quantification assay. This is possi-
bly a resonant of the fact that CID fragmentation favours
the glycosidic transition 1 (242.1n > 126.1), and the low
overall abundance of themodification. Intriguingly, wewere
unable to detect 5hmdC in the P. falciparum DNA up to
a limit of detection of 6 modifications per 107 nucleotides
(Supplementary Figure S7), in spite of detecting ‘5hmC’
with various biochemical techniques. Nonetheless, the addi-
tional peak at 2.75 min is suggestive of a DNAmodification
that is similar to a hydroxymethyl-2′-deoxycytidine based
on the nominal intact mass and the corresponding predic-
tive fragments. Our method, which relies upon C18 chro-
matography, would suggest that this modification is more
hydrophobic in nature than 5hmdC and could be a posi-
tional isomer, for example at position 4 of the nucleotide
ring instead of position 5. The presence of a similar cryptic
peak in the transitions for 5mdC at 5.72 min lends credence
to the suggestion that this might be the precursor to the
5hmC-like modification. These observations based on the
LC-MS chromatogram are, however, speculative, must be
interpreted with caution and need further validation, which
is beyond the scope of this report.
The study of DNAmodifications in malaria parasites has
also identified N6-Methyladenosine (m6A) in the genome
of P. falciparum using a restriction enzyme-based approach
(79) and based on the kinetics of the DNA polymerase
during single molecule real-time sequencing and de novo
genome assembly (80), predicted the genome-wide dis-
tribution of m6A and m4C; however, these marks need
to be validated by MS studies. African trypanosomes
have evolved a unique DNA modification called -D-
Glucopyranosyloxymethyluracil or Base J that acts as tran-
scription terminator in certain kinetoplastid protozoa (81).
Base J is generated by hydroxylation and a subsequent
glycosylation of thymidine by an as yet unknown glyco-
syltransferase (82). This illustrates that different eukary-
otic pathogens use diversified DNA modification mech-
anisms to enable parasitism. Additionally, in the green
alga Chlamydomonas reinhardtii, a recent report by Xue
et al. identified a new 5mC derivative that is generated
by the conjugation of a glyceryl moiety from Vitamin C
to the methyl group of 5mC by a Tet homologue (83);
this strongly emphasises that our knowledge of DNA cy-
tosine modifications is far from complete. Therefore, be-
sides exploring the exact nature of the 5hmC-like base, it
also remains to be seen if oxidative derivatives of 5mC, in-
cluding 5-carboxylcytosine (5caC), 5-formylcytosine (5fC),
5-hydroxymethyluracil (5hmU) and glyceryl-5mC, all of
which are predicted to be epigenetic in nature (8,12,84), ex-
ist in P. falciparum.
In conclusion, our study changes the current dogma on
DNA cytosine methylation in malaria parasites. The iden-
tification of a novel predominant type of cytosine modi-
fication points to a new epigenetic layer that contributes
to mRNA expression. Our work opens up avenues to ex-
plore the pathway that leads to the synthesis of the 5hmC-
like DNAmodification and the reader protein of this mark.
Given that cytidine analogs and DNMT inhibitors block
parasite growth ((28) and our unpublished data), our work
also raises interest to exploit cytosine modifications for new
intervention strategies against malaria parasites.
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